Analysts expect HB Fuller Co (NYSE:FUL) to post earnings per share (EPS) of $1.01 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for HB Fuller’s earnings, with the lowest EPS estimate coming in at $0.94 and the highest estimate coming in at $1.05. HB Fuller reported earnings per share of $0.75 during the same quarter last year, which would suggest a positive year-over-year growth rate of 34.7%. The firm is scheduled to report its next earnings report on Tuesday, January 22nd.
On average, analysts expect that HB Fuller will report full year earnings of $3.11 per share for the current year, with EPS estimates ranging from $3.05 to $3.15. For the next financial year, analysts expect that the firm will post earnings of $3.85 per share, with EPS estimates ranging from $3.60 to $4.03. Zacks Investment Research’s EPS averages are a mean average based on a survey of analysts that cover HB Fuller.
HB Fuller (NYSE:FUL) last issued its quarterly earnings results on Wednesday, September 26th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.04). HB Fuller had a net margin of 4.14% and a return on equity of 13.41%. The company had revenue of $770.11 million for the quarter, compared to analyst estimates of $784.75 million.
In related news, VP Traci L. Jensen sold 4,508 shares of the stock in a transaction on Thursday, August 9th. The shares were sold at an average price of $57.45, for a total transaction of $258,984.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 3.46% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Piedmont Investment Advisors LLC boosted its holdings in HB Fuller by 9.1% during the second quarter. Piedmont Investment Advisors LLC now owns 11,783 shares of the specialty chemicals company’s stock worth $633,000 after buying an additional 983 shares in the last quarter. D.A. Davidson & CO. boosted its holdings in HB Fuller by 20.0% during the second quarter. D.A. Davidson & CO. now owns 6,000 shares of the specialty chemicals company’s stock worth $322,000 after buying an additional 1,000 shares in the last quarter. MetLife Investment Advisors LLC boosted its holdings in HB Fuller by 5.5% during the second quarter. MetLife Investment Advisors LLC now owns 23,194 shares of the specialty chemicals company’s stock worth $1,245,000 after buying an additional 1,200 shares in the last quarter. Ronna Sue Cohen boosted its holdings in HB Fuller by 2.1% during the third quarter. Ronna Sue Cohen now owns 59,214 shares of the specialty chemicals company’s stock worth $3,060,000 after buying an additional 1,227 shares in the last quarter. Finally, OppenheimerFunds Inc. boosted its holdings in HB Fuller by 4.6% during the second quarter. OppenheimerFunds Inc. now owns 28,752 shares of the specialty chemicals company’s stock worth $1,543,000 after buying an additional 1,267 shares in the last quarter. 97.65% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HB Fuller stock opened at $44.46 on Thursday. The company has a current ratio of 2.25, a quick ratio of 1.48 and a debt-to-equity ratio of 2.03. HB Fuller has a 12-month low of $41.26 and a 12-month high of $59.58. The company has a market cap of $2.20 billion, a price-to-earnings ratio of 17.78, a P/E/G ratio of 0.73 and a beta of 1.42.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Thursday, October 18th will be issued a $0.155 dividend. This represents a $0.62 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend is Wednesday, October 17th. HB Fuller’s dividend payout ratio (DPR) is currently 24.80%.
HB Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, and other specialty chemical products worldwide. The company operates through six segments: Americas Adhesives; EIMEA (Europe, India, Middle East and Africa); Asia Pacific; Construction Products; Engineering Adhesives; and Royal Adhesives.
Read More: What are Closed-End Mutual Funds?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.